Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis

J Infect. 2008 May;56(5):376-80. doi: 10.1016/j.jinf.2008.02.014. Epub 2008 Apr 18.

Abstract

Objectives: To investigate the brain inflammation and damage in subacute sclerosing panencephalitis (SSPE), the cerebrospinal fluid (CSF) concentrations of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) were determined in SSPE patients.

Methods: CSF MMP-9 and TIMP-1 levels were measured in 23 patients with SSPE in Papua New Guinea by ELISA.

Results: CSF MMP-9 levels and MMP-9/TIMP-1 ratios of SSPE patients were significantly higher than controls (p<0.001 and p=0.005, respectively). There were no significant differences in CSF TIMP-1 levels between SSPE patients and controls.

Conclusions: Previous studies suggested that CSF MMP-9 levels reflect inflammatory damage to the brain. Our findings suggest that the MMP-9 level in CSF is an indicator of inflammatory damage to the brain in SSPE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Inflammation / cerebrospinal fluid
  • Inflammation / immunology
  • Inflammation / physiopathology
  • Male
  • Matrix Metalloproteinase 9 / cerebrospinal fluid*
  • Papua New Guinea
  • Subacute Sclerosing Panencephalitis / cerebrospinal fluid*
  • Subacute Sclerosing Panencephalitis / diagnosis
  • Subacute Sclerosing Panencephalitis / immunology
  • Subacute Sclerosing Panencephalitis / physiopathology*
  • Tissue Inhibitor of Metalloproteinase-1 / cerebrospinal fluid*

Substances

  • Tissue Inhibitor of Metalloproteinase-1
  • Matrix Metalloproteinase 9